English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Technology/Innovation

+ Technology/Innovation
Jamie Barrand | Nov 23, 2015

FDA extends Clozapine REMS deadlines for prescribers, pharmacies

+ Regulatory
Kerry Goff | Nov 23, 2015

AMHCA expresses disappointment with Helping Families in Mental Health Crisis Act of 2015

+ Regulatory
Kerry Goff | Nov 23, 2015

South Carolina co-op closing creates a scramble for health insurance

+ Technology/Innovation
Jamie Barrand | Nov 22, 2015

FDA approves Ninlaro for patients with multiple myeloma

+ Community
Jamie Barrand | Nov 20, 2015

'Your Time' campaign to increase awareness of chronic obstructive pulmonary disease

+ Regulatory
Jamie Barrand | Nov 20, 2015

ACA allows over $2.4 billion in rebates to return to health insurance consumers since 2011

+ Technology/Innovation
Jamie Barrand | Nov 20, 2015

National Institutes of Health studies link between Alzheimer's and Down syndrome

+ Technology/Innovation
Jamie Barrand | Nov 20, 2015

AbbVie's hepatitis C drug study sees positive results

Trending

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'

+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes

  • « First
  • «
  • …
  • 488
  • 489
  • 490
  • 491
  • 492
  • 493
  • 494
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily